na na
1 day ago
https://cbs4indy.com/business/press-releases/ein-presswire/820992551/gethairmd-and-lionheart-health-announce-alliance-for-commercialization-of-breakthrough-technology-haircell/
GetHairMD and Lionheart Health Announce Alliance for Commercialization of Breakthrough Technology HairCell™
News provided by
EIN Presswire
Jun 11, 2025, 7:45 AM ET
Lionheart Health Technology contributes over 500 patent claims related to hair regeneration and a complete, complementary platform to the GetHairMDTM protocol.
HairCell is a perfect addition to our comprehensive range of solutions, as it offers a non-surgical, in-office approach with minimal discomfort documented results, and high client satisfaction.β
β Paul Herchman, Co-CEO of GetHairMD
IRVINE, CA, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Lionheart Health, a leading energy-based medical device developer and proprietary biologics company for aesthetics and healthspan extension, announced a new partnership with GetHairMD, one of the fastest growing networks of physician-led hair restoration clinics in the United States and an emerging leader in the industry. Through this agreement, GetHairMD becomes the first and only hair restoration medical practice network in the United States to offer HairCell from Lionheart Health, an FDA cleared, patented bioelectric protein expression technology.
HairCell stimulates gene expression to improve circulation, reduce inflammation, improve scalp muscle health, and enhances the youthfulness of scalp tissue. The comfortable procedure involves placing electrodes on the scalp during relaxing in-office sessions. The treatment is completely painless and requires no downtime.
βThis changes everything!β said Paul Herchman, Co-CEO of GetHairMD, βThe patented ground-breaking technology brought forward by the Lionheart Health HairCell bioelectric protein expression platform is at the forefront of innovation and is a perfect complement to the GetHairMD protocol. Our clinical advisory board is excited to lead the way in introducing cell signaling platform to their peers. We believe adding this innovative, patented technology to our already strong treatment offerings, solidifies our industry leadership in supporting our licensed partners and their patients in their hair restoration goals. HairCell is a perfect addition to our comprehensive range of solutions, as it offers a non-surgical, in-office approach with minimal discomfort documented results, and high client satisfaction.β
Lionheart Health's patented bioelectric signals help unlock, amplify, and extend the release of regenerative proteins from the GetHairMD multi-modality treatments.
The Lionheart Health HairCell platform includes patented bioelectric protein expressions for:
1) Stem cell homing via SDF1 and PDGF.
2) Aging reversal, scalp muscle health, and inflammation reduction via Klotho protein stimulation.
3) COL171A stem cell competition and collagen.
4) Tropoelastin for enhancing the youthfulness of scalp tissue for healthy hair follicles.
COL17A1 is heralded in Japan as βthe forever young proteinβ related to its hair and skin regeneration capabilities which promote stem cell competition and collagen building.
βNo other company has a stronger IP and product platform in Klotho stimulation and supplementation technologies than Lionheart Healthβ stated Brian Lasater CTO of Lionheart Health, Inc.
Having a low level of Klotho is identified in many studies as a primary underlying cause of premature aging, including hair loss.
Lionheart Health, Inc. won the Allergan Aesthetics ULP Innovation in Medical Aesthetics Award in part for its breakthroughs in skin and hair regeneration research. On May 12th, it was announced that Lionheart Health, out of 596 competitors, is one of 40 finalists in the XPRIZE health span competition and is in the running to win the $81 million Grand Prize for reversing aging by 20 years.
βThe HairCell platform is a unique, groundbreaking innovation in cell signaling for scalp and hair follicle health. GetHairMD is singularly focused on the hair growth market, and not only are our product lines synergistic, but our commercialization strategies align as well utilizing a licensing/franchising model with comprehensive support provided to licensees,β stated Howard Leonhardt, Inventor and Co-CEO of Lionheart Health, Inc.
The HairCell FDA clearance is for:
β’ Reducing pain/inflammation
β’ Restoring scalp muscle health
β’ Improving scalp circulation
βWe are committed to ensuring our HairCell and GetHairMD joint licensees/franchisees develop thriving, profitable practices with highly satisfied clients that help grow their businesses further with a steady stream of referrals,β stated Scott Hoots, Co-CEO at Lionheart Health, Inc., and leader of their licensing operations.
na na
1 day ago
Alright so I asked Chat GPT.
This Lionheart Health technology β centered on bioelectric-controlled protein expression β could hold promise as a complementary or even alternative treatment to opioids, but several critical factors would influence its real-world viability. Let's break it down.
🧠 Biological Plausibility: Can It Work as an Opiate Alternative?
What it does:
Their core tech uses bioelectric stimulation to trigger targeted protein expressions, such as:
SDF-1 & PDGF: Stem cell homing factors for repair and regeneration
Klotho: A protein linked to cognitive health, sexual function, and longevity
Other factors: Potentially including natural anti-inflammatory or analgesic proteins (not specified, but possible)
If they can stimulate the bodyβs own repair pathways and anti-inflammatory systems, then:
✅ Chronic pain due to degeneration (joints, nerves, tissues) may improve
✅ Neuropathic or inflammatory pain might be alleviated without opiates
✅ Mood and energy may increase if Klotho and related proteins act on aging or depression-linked pathways
This is conceptually similar to how low-level electrical stimulation is used for pain relief in TENS units β but their method claims to modulate protein production, which is far more advanced.
🔬 Evidence Gap: What's Missing?
Concerns before it could compete with opioids at scale:
Direct clinical trials for pain relief:
They mention trials for skin, hair, sexual health, and aging, but not chronic pain, post-surgery recovery, or opioid withdrawal.
Long-term reliability and repeatability:
Opioids are effective because they consistently numb pain. If this tech is inconsistent or only works for some types of pain, it wonβt replace opiates β at best, it could reduce the need for them.
Mechanism transparency:
Protein expression for regeneration is not the same as modulating nociception (pain signaling). Theyβd need to show impact on:
Inflammatory cytokines
Nerve repair
Pain perception centers in the brain
FDA pathway:
Pain relief devices or therapeutics must pass rigorous efficacy standards and safety thresholds. Opiate alternatives are heavily scrutinized.
🧭 Strategic Fit as an Alternative
If refined and trialed properly, this technology could be a powerful non-addictive adjunct or alternative in areas like:
Use Case Opiate Alternative Potential
Joint pain ✅ High β regenerative pathways relevant
Neuropathic pain 🟡 Maybe β needs trials
Post-op recovery 🟢 Good candidate for adjunct use
Fibromyalgia 🟡 Uncertain β complex multi-system disease
Opiate withdrawal 🟡 Possibly helpful β mood regulation, but speculative
💡 Market Implication
If this therapy reduced even 20β30% of opioid prescriptions in targeted settings (e.g., orthopedic clinics, sports medicine, or geriatrics), it would:
Create enormous value β socially and economically
Fit into longevity + pain + wellness clinics
Be sellable to conservative pain physicians looking for less risky treatments
🧪 Final Thoughts
🔍 Bottom Line:
Yes, it has potential, especially for regenerative and inflammatory pain conditions. But to be taken seriously as an opiate alternative, dedicated pain studies must prove:
Consistent pain reduction
Superior safety profile
Functional outcomes (mobility, quality of life)
Until then, it's promising β but not yet a substitute.
Would you like help drafting a proposal or outline for how they could position this as an opiate-reduction solution?
You said:
So if it could do it while having software lock outs to prevent abuse?
ChatGPT said:
Yes β software lockouts could make this a very viable opiate alternative, especially in the current climate where non-addictive, controlled, and targeted treatments are in high demand.
Here's a breakdown of why software-controlled bioelectric therapy could excel, and how lockouts would make it even more attractive to regulators and clinicians:
✅ Advantages of Software Lockouts in Bioelectric Pain Therapy
Feature Benefit
Limited-use sessions Prevents overuse or placebo "crutch" behavior β unlike opioids, where tolerance escalates.
Prescription-based access Just like a digital prescription: clinicians can "unlock" treatment durations, frequencies, or areas.
Audit logs Clinics can review patient usage for compliance, allowing feedback and early intervention.
Adaptive dosing algorithms Adjusts electrical signal parameters based on response, age, or injury site β unlike opiates, which are chemically one-size-fits-all.
Remote supervision Telehealth-compatible. Doctors could monitor or adjust treatment plans in real time.
🧠 Ethical & Regulatory Advantages
Avoids physical addiction β even in patients with pain-related dopamine reward loops
No chemical ingestion β safe for liver, kidneys, and those with multi-drug sensitivities
Cannot be resold or shared β unlike pills
Supports tapering β software could gradually reduce stimulation as patient improves
🏥 Clinical Use Scenarios
Post-operative recovery
Prescribed 10 days of treatment with 3 daily sessions
Software lockout after day 10 unless reauthorized
Chronic pain management
Clinic-monitored usage with monthly reviews
Algorithms adjust intensity and frequency based on improvement
Rehabilitation
Physical therapists coordinate use with movement exercises
App-based progress dashboard
🧩 Comparison to Opioids
Criteria Opioids Bioelectric w/ Lockouts
Addiction Risk High None
Physical Side Effects Constipation, tolerance, overdose risk Minimal (skin irritation, rare overstimulation)
Supervised Use Often lax Strict, programmable
Tapering Built-In No Yes, customizable
Psychological Dependence Common Controllable with soft limits
🚧 Remaining Needs Before Clinical Adoption
FDA Device Classification (likely Class II if safety is proven)
Pain-targeted clinical trials (ideally with opioid comparison arms)
Insurance coverage frameworks β software locks help make billing and compliance easier
Clear contraindications (e.g., pacemakers, seizure risk, etc.)
🧠 Thought:
You could even build opioid tapering protocols using this:
Patients reduce opioid intake while increasing bioelectric treatments
Software adjusts timing/strength as the body adapts
Clinician reviews pain scores + usage patterns weekly
Would you like a hypothetical clinical protocol mockup for "opioid replacement using bioelect
Winsmore
2 days ago
The video that I posted earlier of the βLionheart Health 2025 ElectroMed 240 Bioelectric Stimulator currently in testingβ had very bad audio but I was able to locate another video with text that I transcribed, and I AM BLOWN AWAY!!! It appears to be a demonstration in which the device itself describes its capabilities, etc. I misspoke earlier, the device is actually the latest edition of the Wellness Pro. This is incredible!! Transcription and video below.
Lionheart Health 2025 Model ElectroMed 240 Bioelectric Stimulator currently in testing
So, Iβm Infinity, the latest edition of the Wellness Pro. My creators were thrilled to allow me to show you how I can simplify your life by easing your pain. Iβm designed to seamlessly integrate into your daily routine, allowing you and your doctor to custom tailor the treatment specifically for you. Miss doctorβs appointments? Not anymore. Very soon, I should be able to integrate with your calendar to remind you of your upcoming appointments with your doctor. Even better, for doctors participating in our program, I can bring a video call Qron code to your phone where you can consult directly with a doctor without need to go to his office. I can gather feedback from you regarding your pain and treatment progress and share that with your doctor if you like, minimizing time needed to go over your problems. My capabilities are allowing doctors to share treatment programs results, allowing them to come up with even better solutions for you. A small built-in encyclopedia will allow you to get more info on the problems you are facing. Did I mention that my platform is expandable? As the company is getting clearances for specific treatments, they will be available for you with a touch of button. PTSD, insomnia, depression, anxiety, peripheral neuropathy, just to name a few, without need to buy new devices. My warranty is like my name. Infinite, if you choose it to be all that in a modern, slip design you are seeing in front of you. Iβm more than just a smart electrotherapy device. I am future of it. Accuracy of my output is so high that company is challenging any manufacturer that has a device in my category to match it. Even better, find a more versatile device on the market and you could possibly have me free of charge. My professional edition designed for doctors has even more features. Networking capability, for example, will allow doctors to monitor treatment progress of all devices in the network from one location. Reporting capabilities are designed to reduce time needed for billing, permitting doctors to spend more time with their patients and less time doing paperwork. At the end, I have to say thank you for your time. Everyone at Electro Medical are truly excited for you to experience the power of Infinity. Oh, one last thing before I go. It takes time to build a good thing, but to build a great thing, it takes a little longer. See you soon. Electromedical Technologies. Thank you.
https://www.youtube.com/shorts/o9QeeRBZE80
Winsmore
2 days ago
Donβt know. About 3 or 4 yrs ago, the VA referred a friend of mine to a 3rd party, I think it was Regenesis here in Scottsdale, AZ, for electrotherapy due to back pain. A case manager or nurse from Regenesis delivered the equipment to his home in a large heavy-duty case and provided instructions. He had to insert something into the machine that would allow him only 1 hour of treatment in the morning and then again in the evening. Kind of cumbersome. The machine was given to him on a rental basis for a specific amount of time and a nurse called him periodically to oversee his treatment. He had to re-order the thing that goes into the machine numerous times and sometimes it did not work properly. Anyway, he ended up using the machine for about 6 months and then the company picked up the equipment from his home. The VA said that it costs them $5,000 rental fee per month. So that was $30,000 over the course of 6 months!!
Devices in general are getting more compact, sophisticated and interactive now and cost less. They can also be more easily adapted to changes in technology.
Winsmore
3 days ago
https://lionhearthealthstim.com/lionheart-health-and-electromedical-technologies-announce-joint-venture-in-accelerated-wound-healing/?srsltid=AfmBOoq7yhhivSDvQeotVLFYPt7GemGj9Cxg7EruwbYl6rHMZ3Q6EOcs
Lionheart Health and ElectroMedical Technologies Announce Joint Venture in Accelerated Wound Healing
Mar 26, 2025
Mission Viejo, CA (Newsworthy.ai) Wednesday Mar 26, 2025 @ 7:00 AM Pacific β
Two industry innovation leaders have teamed up to transform the field of accelerated wound healing. The Lionheart Health, Inc. and ElectroMedical Technologies (OTC:EMED) joint venture combines Lionheart Healthβs patented bioelectric signaling software for regeneration and accelerated healing with ElectroMedβs advanced device technology platform. This partnership is intended to make great leap strides in addressing critical patient needs such as avoiding limb amputation by significantly enhancing treatment outcomes in wound care.
Lionheart Health, Inc. is a spin out of Leonhardt Ventures LLC known for over 4 decades of breakthrough innovations in healthcare. Over 600,000 patients have been treated with Leonhardt inventions that generated over $2 billion in annual revenues for licensees and acquirers in 2024 alone.
Matthew Wolfson, CEO of ElectroMed Technologies, stated, βBy integrating Lionheart Healthβs patented bioelectric accelerated healing protein expressions and our first in class device technology, we have created the ultimate accelerated wound healing solution that we believe is destined to transform patient wound care forward for the next 100 years. The encouraging results from our respective initial tests are a testament to the potential of this partnership. We believe this technology may contribute most in treating diabetic ulcers.β
A Partnership of Continued Research and Commercialization
Following the promising safety and efficacy outcomes of pilot studies of both firmsβ wound healing products the joint venture is preparing to launch new combination clinical studies. The intended aim of these new studies is to significantly accelerate complete healing and long term outcomes in wound management and to prevent limb amputations.
A new planned wound care clinical study will have these arms (about to be submitted for independent IRB approval):
1. Bioelectric stimulation alone.
2. Bioelectric stimulation + bioelectric enhanced Super PRF TM.
3. Bioelectric stimulation + bioelectric enhanced Super PRF TM + amniotic sourced membrane grafts
4. All of the above (3) + stromal fraction derived from adipose tissue injections or klotho expressing stem cells (where available).
β’ PRF centrifuges for this study will be provided by BioPRF Florida https://bio-prf.com
β’ Adipose tissue processing devices will be provided by SynovaLife Pasadena https://www.synovalife.com
Lionheart Health-ElectroMed 240 Stimulator
In previous stand-alone pilot studies completed in patients with non-healing wounds on the soon to be amputated list in The Czech Republic, Mexico and the USA > 90% of limbs treated were saved.
Lionheart Health, Inc. has over 500 patent claims related to bioelectric protein expressions, tissue regeneration and accelerated healing. Electromedical Technologies founded in 2007 has over 18 yearsβ experience developing and manufacturing electrical stimulation devices for treating pain and inflammation and other related disorders. The two organizations have a shared vision of enhancing patient outcomes in wound care and reducing long term care and lost opportunity costs for society. There are 185,000 amputations in the USA every year, most of them related to non-healing wounds, and this joint venture team has a goal to cut that by more than 1/2 within the decade.
Lionheart Health, Inc. is in the process of opening up, primarily via licensing, 124 clinics worldwide that will be trained and certified to practice their patented bioelectric treatment protocols. The plan is to make this wound care technology available to qualified clinics as an add on module license. The joint venture will receive 7% gross sales royalty on each patient service.
For more information visit: Lionheart Health and Electromedical Technologies.
Forward looking statements subject to change without notice.
Contacts
Howard Leonhardt: howard@leonhardtventures.com
Mathew Wolfson: ceo@electromedtech.com
**********************************************
Lionheart Health 2025 Model ElectroMed 240 Bioelectric Stimulator currently in testing ...
Videos
2:41
YouTube · Howard Leonhardt, Executive Chairman & CEO at Lionheart Health, Inc.
3 days ago
na na
3 days ago
Lionheart Health Presentation β Transcript Summary (Cleaned)
00:00:04
Hello everyone. Itβs late in the afternoon, and I know some of you have been here since this morning. Iβll try to wake you up a bit, because this presentation concerns everyone.
We are Lionheart Health, and we are targeting aging. We have over 500 patent claims and data from more than 1,000 patients, and our goal is to reverse aging by 20 years using bioelectric-controlled protein expression β which Iβll explain shortly.
This is our medspa location in Newport Beach, part of our expanding clinical model. We license our patented technology via exclusive territorial licenses (15β25 mile radius). We plan to open 124 clinics over the next 60 months. We already have one in Manhattan and seven other locations.
00:01:10
The healthspan longevity industry will eventually dwarf all other industries in size and market capitalization. It requires unprecedented sophistication to optimize its opportunities.
We believe this industry has the potential to provide not only exceptional returns on investment but also immense benefit to humanity.
The biotech company that proves it can achieve real anti-aging results will become the next Google. We say this with humility β or perhaps boldness β because we believe Lionheart Health has a shot at that role.
00:01:44
We're a team of inventors. We have a laboratory near UC Irvine, in the UCI Cove incubator.
Our first paper on bioelectric regeneration was published in Circulation (the Journal of the American Heart Association) in 1999. Since then, weβve regenerated over 100 hearts worldwide.
Lionheart Health is a spinout of Leonhardt Ventures, which is now in its 43rd year. Last year alone, over $2 billion in revenue was derived from Leonhardt Ventures companies.
Lionheart Health has secured the exclusive rights to all Leonhardt patents as they apply to medical aesthetics and aging reversal.
00:02:47
So, what is bioelectric-controlled protein expression?
When you scrape your knee, a bioelectric signal is sent to the brain indicating injury. The brain responds by sending a precise frequency and pulse duration back to the injured area, triggering the release of proteins like SDF-1 and PDGF, which are known as stem cell homing factors.
These factors attract your bodyβs own stem cells to the injury site. Once enough cells gather, a starvation signal is sent, switching the mode from proliferation to differentiation β essentially, the stem cells figure out what they need to become.
What weβve patented is the ability to manipulate that process, directing stem cells where we want them:
Stimulate the knee β cells go to the knee
Stimulate the face β cells go to the face
Stimulate the scalp or sexual organs β same thing
These are among our biggest markets.
00:03:45
We hold patents or pending claims for over 80 protein expressions, but one stands out: Klotho.
If you're low in circulating Klotho, you're aging faster than you should.
In 1997, Professor Kuro discovered Klotho in Japan. When he accidentally blocked Klotho in mice, they died 80% earlier, experiencing every negative symptom of aging earlier:
Hair loss
Cognitive decline
Sexual health deterioration
When he supplemented Klotho, the mice lived 30% longer and avoided aging-related conditions.
Weβre now taking this research into human applications.
00:04:51
Weβre conducting placebo-controlled studies and organizing exclusive medspa clinics to apply this technology.
We just licensed a clinic in Scottsdale, securing top real estate near Fashion Square. They paid:
$40,000 for the license
$25,000 for pre-programmed equipment
We earn a 7% royalty on their sales
iHeart Radio is coming to our lab this Friday β weβre creating a nationwide marketing agreement. For each clinic, if they spend $10K on marketing, weβll match it with $10K ourselves.
00:05:53
In December 2023, we won the Innovation of the Year award from Allergan Aesthetics, the Orange County-based company sold to AbbVie for $63 billion.
We won for our skin and hair regeneration technology.
Notable users of our product include:
Jessica Alba
Dan Marino
Mike Singletary
Mariel Hemingway
Chris Hemsworth (just ordered his suit)
00:06:24
Our pitch is simple:
Be the only medspa in your town with patented, one-of-a-kind therapies β for skin, hair, joints, sexual health, body toning, and full aging reversal.
Skin is the gateway to aging.
People come in for wrinkles or hair loss, and our trained doctors and nurses introduce them to our healthspan longevity program β a higher-value offering.
If a man comes in with erectile dysfunction, we tell him, βThatβs a warning light β better now than a stroke or heart attack.β That opens the door to longer-term preventative care.
00:07:47
We also offer at-home devices. Weβre essentially a software company β we partner with hardware providers but load our tech onto their devices.
Like a video game console, customers buy the stimulator and can then download specific programs:
Breast augmentation
Gut health
Addiction treatment
Hair, skin, joints, sexual health, and more
We earn royalties on every software program purchased.
00:08:42
We recently advanced to the next round of the $11M XPRIZE for Healthspan Extension, the largest competition in history for anti-aging science.
Our CEO, Scott Hoots, previously sold 235 regenerative medicine franchises. Our goal of 124? He calls it βmodest.β
Weβve also added Chad Hacker, former VP of Consumer & Digital at Allergan. He left a global leader to join us because of our results β "recruiting your own stem cells for a natural look is the future beyond Botox."
00:09:42
We're currently raising $3 million at a $27 million valuation.
Weβve already secured $1.2 million, with several term sheets pending.
A major VC asked us to consolidate our planned $3M and $20M offerings into a single $23M round β we agreed. Our second meeting is tomorrow.
This shows serious momentum and institutional interest.
00:10:13
And yes, we have a track record:
In 2009, investors who put in $100,000 received $6.3 million by 2015 from one of our ventures β a 62x return.
We know how to create innovation, lead markets, and deliver ROI.
We invite you to visit our clinic, explore a partnership, or join us on this journey.
Thank you. [Applause]
Winsmore
3 days ago
No, Lionheart Health and Lionheart Holdings are not the same company, but they are related. Lionheart Health is a regenerative biotechnology company, while Lionheart Holdings is a SPAC (Special Purpose Acquisition Company) founded by Lionheart Capital, according to a news article from Renaissance Capital. Lionheart Capital is the investment firm that founded Lionheart Holdings. Lionheart Health is also a portfolio company of Lionheart Ventures, which is the parent company of Lionheart Longevity and Wellness.
Here's a breakdown:
Lionheart Health: A regenerative biotechnology company focusing on Bioelectric Stimulation (BES) and biologics.
Lionheart Holdings: A SPAC, a company formed to acquire a private company and make it public.
Lionheart Capital: The diversified investment firm that founded Lionheart Holdings.
Lionheart Ventures: The parent company of Lionheart Health and Lionheart Longevity and Wellness.
In essence, Lionheart Health is a company within the broader Lionheart ecosystem, while Lionheart Holdings is a separate entity, also part of that ecosystem, through its connection to Lionheart Capital.
Winsmore
4 days ago
https://lionhearthealthstim.com/wp-content/uploads/2023/08/LIONHEART-HEALTH-Pitch-Deck-Mainstage-PDF-8.10.2022.pdf
Roll-up Plan and IPO
β’ All key suppliers have been alerted to the opportunity to roll up into Lionheart Health, Inc. in Q1 2025
based on 1.2X their 2023 year-end sales.
β’ If all supplier companies accept this offer, and Lionheart Health agrees, the Companyβs projected
collective sales in 2025 would exceed $250 million.
β’ Plan is for an IPO in 2025 following this roll-up, dependent on market conditions.
β’ The combination of sales and capabilities of all partner and supplier companies would create an
International Bioelectric Regeneration and Wellness Corporation with a strong presence in major
worldwide markets.
Investment Opportunity and Use of Funds
INVESTMENT OPPORTUNITY
$3 million of Series A Common Stock (the βSharesβ) in a private placement equity offering.
USE OF PROCEEDS
β’ 75% Marketing, Sales, Operations, Customer Service, Product packaging, Training,
Logistics, and Distribution
β’ 25% General Corporate Purposes and Expenses: Research, Legal, Regulatory,
Accounting, Quality, Administrative, and Investment in suppliers